283 related articles for article (PubMed ID: 34535993)
61. Smoking and COVID-19 outcomes: an observational and Mendelian randomisation study using the UK Biobank cohort.
Clift AK; von Ende A; Tan PS; Sallis HM; Lindson N; Coupland CAC; Munafò MR; Aveyard P; Hippisley-Cox J; Hopewell JC
Thorax; 2022 Jan; 77(1):65-73. PubMed ID: 34580193
[TBL] [Abstract][Full Text] [Related]
62. Association between Long COVID and Overweight/Obesity.
Vimercati L; De Maria L; Quarato M; Caputi A; Gesualdo L; Migliore G; Cavone D; Sponselli S; Pipoli A; Inchingolo F; Scarano A; Lorusso F; Stefanizzi P; Tafuri S
J Clin Med; 2021 Sep; 10(18):. PubMed ID: 34575251
[TBL] [Abstract][Full Text] [Related]
63. Factors affecting duration of SARS-Cov-2 viral shedding in mildly symptomatic patients isolated in a community facility.
Cheng HM; Zhao X; Lim WS; Tan BJM; Tey HL
PLoS One; 2021; 16(9):e0257565. PubMed ID: 34570805
[TBL] [Abstract][Full Text] [Related]
64. Is the male disadvantage real? Cross-national variations in sex gaps in COVID-19 incidence and mortality.
Kim H; Fox AM; Kim Y; Kim R; Bae G; Kang M
Glob Public Health; 2021 Dec; 16(12):1793-1803. PubMed ID: 34569902
[No Abstract] [Full Text] [Related]
65. An analysis of antibody responses and clinical sequalae of the Sinopharm HB02 COVID19 vaccine in dialysis patients in the United Arab Emirates.
Holt SG; Mahmoud S; Ahmed W; Acuna JM; Al Madani AK; Eltantawy I; Zaher WA; Goodier GJ; Al Kaabi NA; Al Obaidli AA
Nephrology (Carlton); 2022 Mar; 27(3):260-268. PubMed ID: 34569677
[TBL] [Abstract][Full Text] [Related]
66. Early combination therapy with hydroxychloroquine and azithromycin reduces mortality in 10,429 COVID-19 outpatients.
Million M; Lagier JC; Tissot-Dupont H; Ravaux I; Dhiver C; Tomei C; Cassir N; Delorme L; Cortaredona S; Amrane S; Aubry C; Bendamardji K; Berenger C; Doudier B; Edouard S; Hocquart M; Mailhe M; Porcheto C; Seng P; Triquet C; Gentile S; Jouve E; Giraud-Gatineau A; Chaudet H; Camoin-Jau L; Colson P; Gautret P; Fournier PE; Maille B; Deharo JC; Habert P; Gaubert JY; Jacquier A; Honore S; Guillon-Lorvellec K; Obadia Y; Parola P; Brouqui P; Raoult D
Rev Cardiovasc Med; 2021 Sep; 22(3):1063-1072. PubMed ID: 34565108
[TBL] [Abstract][Full Text] [Related]
67. Distinct single-component adjuvants steer human DC-mediated T-cell polarization via Toll-like receptor signaling toward a potent antiviral immune response.
Roßmann L; Bagola K; Stephen T; Gerards AL; Walber B; Ullrich A; Schülke S; Kamp C; Spreitzer I; Hasan M; David-Watine B; Shorte SL; Bastian M; van Zandbergen G
Proc Natl Acad Sci U S A; 2021 Sep; 118(39):. PubMed ID: 34561306
[TBL] [Abstract][Full Text] [Related]
68. A distinct association of inflammatory molecules with outcomes of COVID-19 in younger versus older adults.
Shin JJ; Jeon S; Unlu S; Par-Young J; Shin MS; Kuster JK; Afinogenova Y; Kang Y; Simonov M; Buller G; Bucala R; Kang I
Clin Immunol; 2021 Nov; 232():108857. PubMed ID: 34560283
[TBL] [Abstract][Full Text] [Related]
69. Clinical outcomes of patients with and without HIV hospitalized with COVID-19 in England during the early stages of the pandemic: a matched retrospective multi-centre analysis (RECEDE-C19 study).
Lee MJ; Snell LB; Douthwaite ST; Fidler S; Fitzgerald N; Goodwin L; Hamzah L; Kulasegaram R; Lawrence S; Lwanga J; Marchant R; Orkin C; Palfreeman A; Parthasarathi P; Pareek M; Ring K; Sharaf H; Shekarchi-Khanghahi E; Simons R; Teh JJ; Thornhill J; van Halsema C; Williamson M; Wiselka M; Nori A; Fox J; Smith C
HIV Med; 2022 Feb; 23(2):121-133. PubMed ID: 34555242
[TBL] [Abstract][Full Text] [Related]
70. Guillain-Barré syndrome after SARS-CoV-2 infection in an international prospective cohort study.
Luijten LWG; Leonhard SE; van der Eijk AA; Doets AY; Appeltshauser L; Arends S; Attarian S; Benedetti L; Briani C; Casasnovas C; Castellani F; Dardiotis E; Echaniz-Laguna A; Garssen MPJ; Harbo T; Huizinga R; Humm AM; Jellema K; van der Kooi AJ; Kuitwaard K; Kuntzer T; Kusunoki S; Lascano AM; Martinez-Hernandez E; Rinaldi S; Samijn JPA; Scheidegger O; Tsouni P; Vicino A; Visser LH; Walgaard C; Wang Y; Wirtz PW; Ripellino P; Jacobs BC;
Brain; 2021 Dec; 144(11):3392-3404. PubMed ID: 34553216
[TBL] [Abstract][Full Text] [Related]
71. Safety and heart rate changes in Covid-19 patients treated with Remdesivir.
Brunetti ND; Poliseno M; Bottalico IF; Centola A; Montemurro L; Sica S; Santantonio T; Lo Caputo S
Int J Infect Dis; 2021 Nov; 112():254-257. PubMed ID: 34551344
[TBL] [Abstract][Full Text] [Related]
72. Safety and Immunogenicity of a Recombinant Adenovirus Type-5-Vectored Coronavirus Disease 2019 (COVID-19) Vaccine With a Homologous Prime-Boost Regimen in Healthy Participants Aged ≥6 Years: A Randomized, Double-Blind, Placebo-Controlled, Phase 2b Trial.
Zhu F; Jin P; Zhu T; Wang W; Ye H; Pan H; Hou L; Li J; Wang X; Wu S; Wang Y; Gou J; Huang H; Wu H; Wang X; Chen W
Clin Infect Dis; 2022 Aug; 75(1):e783-e791. PubMed ID: 34551104
[TBL] [Abstract][Full Text] [Related]
73. The Impact of Prior Infection and Age on Antibody Persistence After Severe Acute Respiratory Syndrome Coronavirus 2 Messenger RNA Vaccine.
Fraley E; LeMaster C; Khanal S; Banerjee D; Pastinen T; Grundberg E; Selvarangan R; Bradley T
Clin Infect Dis; 2022 Aug; 75(1):e902-e904. PubMed ID: 34551091
[TBL] [Abstract][Full Text] [Related]
74. Clinical Characteristics of Multisystem Inflammatory Syndrome in Adults: A Systematic Review.
Patel P; DeCuir J; Abrams J; Campbell AP; Godfred-Cato S; Belay ED
JAMA Netw Open; 2021 Sep; 4(9):e2126456. PubMed ID: 34550381
[TBL] [Abstract][Full Text] [Related]
75. Characterising proteolysis during SARS-CoV-2 infection identifies viral cleavage sites and cellular targets with therapeutic potential.
Meyer B; Chiaravalli J; Gellenoncourt S; Brownridge P; Bryne DP; Daly LA; Grauslys A; Walter M; Agou F; Chakrabarti LA; Craik CS; Eyers CE; Eyers PA; Gambin Y; Jones AR; Sierecki E; Verdin E; Vignuzzi M; Emmott E
Nat Commun; 2021 Sep; 12(1):5553. PubMed ID: 34548480
[TBL] [Abstract][Full Text] [Related]
76. High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19.
Lourda M; Dzidic M; Hertwig L; Bergsten H; Palma Medina LM; Sinha I; Kvedaraite E; Chen P; Muvva JR; Gorin JB; Cornillet M; Emgård J; Moll K; García M; Maleki KT; Klingström J; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg KJ; Sandberg JK; Henter JI; Folkesson E; Gredmark-Russ S; Sönnerborg A; Eriksson LI; Rooyackers O; Aleman S; Strålin K; Ljunggren HG; Björkström NK; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers BJ;
Proc Natl Acad Sci U S A; 2021 Oct; 118(40):. PubMed ID: 34548411
[TBL] [Abstract][Full Text] [Related]
77. Low-dose radiation therapy for COVID-19 pneumonia: a pilot study.
Sharma DN; Guleria R; Wig N; Mohan A; Rath G; Subramani V; Bhatnagar S; Mallick S; Sharma A; Patil P; Madan K; Soneja M; Thulkar S; Singh A; Singh S
Br J Radiol; 2021 Oct; 94(1126):20210187. PubMed ID: 34545760
[TBL] [Abstract][Full Text] [Related]
78. Immune and cellular damage biomarkers to predict COVID-19 mortality in hospitalized patients.
Lombardi C; Roca E; Bigni B; Bertozzi B; Ferrandina C; Franzin A; Vivaldi O; Cottini M; D'Alessio A; Del Poggio P; Conte GM; Berti A
Curr Res Immunol; 2021; 2():155-162. PubMed ID: 34545350
[TBL] [Abstract][Full Text] [Related]
79. Dexamethasone or methylprednisolone therapy in covid-19 pneumonia: A retrospective and comparative study of 513 cases.
El Mezzeoui S; El Aidouni G; Merbouh M; El Kaouini A; Aftiss FZ; Berrichi S; Berrajaa S; Bkiyer H; Abda N; Housni B
Ann Med Surg (Lond); 2021 Oct; 70():102858. PubMed ID: 34545308
[TBL] [Abstract][Full Text] [Related]
80. High genetic barrier to SARS-CoV-2 polyclonal neutralizing antibody escape.
Schmidt F; Weisblum Y; Rutkowska M; Poston D; DaSilva J; Zhang F; Bednarski E; Cho A; Schaefer-Babajew DJ; Gaebler C; Caskey M; Nussenzweig MC; Hatziioannou T; Bieniasz PD
Nature; 2021 Dec; 600(7889):512-516. PubMed ID: 34544114
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
